Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Vrinten C, van der Zwaag AM, Weinreich SS, Scholten RJ, Verschuuren JJ.

Cochrane Database Syst Rev. 2014 Dec 17;(12):CD010028. doi: 10.1002/14651858.CD010028.pub2. Review.

PMID:
25515947
2.

Acetylcholinesterase inhibitor treatment for myasthenia gravis.

Mehndiratta MM, Pandey S, Kuntzer T.

Cochrane Database Syst Rev. 2014 Oct 13;(10):CD006986. doi: 10.1002/14651858.CD006986.pub3. Review.

PMID:
25310725
3.

Acetylcholinesterase inhibitor treatment for myasthenia gravis.

Mehndiratta MM, Pandey S, Kuntzer T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006986. doi: 10.1002/14651858.CD006986.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD006986.

PMID:
21328290
4.

The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.

Mullaney P, Vajsar J, Smith R, Buncic JR.

Ophthalmology. 2000 Mar;107(3):504-10.

PMID:
10711889
5.

Medical and surgical treatment for ocular myasthenia.

Benatar M, Kaminski H.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD005081. doi: 10.1002/14651858.CD005081.pub3. Review.

6.

Medical and surgical treatment for ocular myasthenia.

Benatar M, Kaminski H.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005081. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD005081.

PMID:
16625623
7.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka KV.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002277. doi: 10.1002/14651858.CD002277.pub4. Review.

PMID:
23235588
8.

Congenital myasthenic syndromes and transient myasthenia gravis.

Gajda A, Szabó H, Gergev G, Karcagi V, Szabó N, Endreffy E, Túri S, Sztriha L.

Ideggyogy Sz. 2013 May 30;66(5-6):200-3.

PMID:
23909021
9.

Plasma exchange for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2002;(4):CD002275. Review.

PMID:
12519572
10.

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.

Vrinten C, Lipka AF, van Zwet EW, Schimmel KJ, Cornel MC, Kuijpers MR, Hekster YA, Weinreich SS, Verschuuren JJ.

BMJ Open. 2015 Jul 16;5(7):e007863. doi: 10.1136/bmjopen-2015-007863.

11.

Treatment for Lambert-Eaton myasthenic syndrome.

Keogh M, Sedehizadeh S, Maddison P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD003279. doi: 10.1002/14651858.CD003279.pub3. Review.

PMID:
21328260
12.

Corticosteroids for myasthenia gravis.

Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002828. Review.

PMID:
15846640
13.

Myasthenia gravis and congenital myasthenic syndromes in dogs and cats: A history and mini-review.

Shelton GD.

Neuromuscul Disord. 2016 Jun;26(6):331-4. doi: 10.1016/j.nmd.2016.03.002. Epub 2016 Mar 10. Review.

PMID:
27080328
14.

Update on juvenile myasthenia gravis.

Liew WK, Kang PB.

Curr Opin Pediatr. 2013 Dec;25(6):694-700. doi: 10.1097/MOP.0b013e328365ad16. Review.

PMID:
24141560
15.

Treatment for Lambert-Eaton myasthenic syndrome.

Maddison P, Newsom-Davis J.

Cochrane Database Syst Rev. 2003;(2):CD003279. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003279.

PMID:
12804456
16.

A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.

Webster RG, Cossins J, Lashley D, Maxwell S, Liu WW, Wickens JR, Martinez-Martinez P, de Baets M, Beeson D.

Exp Neurol. 2013 Oct;248:286-98. doi: 10.1016/j.expneurol.2013.06.012. Epub 2013 Jun 21.

PMID:
23797154
17.

Immunosuppressive agents for myasthenia gravis.

Hart IK, Sathasivam S, Sharshar T.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005224. Review.

PMID:
17943844
18.

Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.

Utomo E, Groen J, Blok BF.

Cochrane Database Syst Rev. 2014 May 24;(5):CD004927. doi: 10.1002/14651858.CD004927.pub4. Review.

PMID:
24859260
19.

Thymectomy for non-thymomatous myasthenia gravis.

Cea G, Benatar M, Verdugo RJ, Salinas RA.

Cochrane Database Syst Rev. 2013 Oct 14;(10):CD008111. doi: 10.1002/14651858.CD008111.pub2. Review.

PMID:
24122674
20.

Interventions for fatigue in peripheral neuropathy.

White CM, van Doorn PA, Garssen MP, Stockley RC.

Cochrane Database Syst Rev. 2014 Dec 18;(12):CD008146. doi: 10.1002/14651858.CD008146.pub2. Review.

PMID:
25519471

Supplemental Content

Support Center